[Federal Register: December 2, 2003 (Volume 68, Number 231)]
[Notices]
[Page 67480]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02de03-108]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances, Notice of Registration
By Notice dated July 22, 2003, and published in the Federal
Register on August 5, 2003, (68 FR 46227), Wildlife Laboratories, Inc.,
1401 Duff Drive, Suite 600, Fort Collins, Colorado 80524, made
application by renewal to the Drug Enforcement Administration for
registration as a bulk manufacturer of Carfentanil (9743), a basic
class of controlled substance listed in Schedule II.
The firm plans to manufacture the listed controlled substance for
distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in title 21, United States Code, section 823(a) and
determined that the registration of Wildlife Laboratories, Inc. to
manufacture the listed controlled substances is consistent with the
public interest at this time. DEA has investigated Wildlife
Laboratories, Inc. to ensure that the company's registration is
consistent with the public interest. This investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant
Administrator, Office of Diversion Control, hereby orders that the
application submitted by the above firm for registration as a bulk
manufacturer of the basic class of controlled substance listed is
granted.
Dated: November 14, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 03-29970 Filed 12-1-03; 8:45 am]
BILLING CODE 4410-09-M